Lessons from the Belgian experience with regulatory control during the COVID-19 pandemic for the implementation of the European IVD regulation 2017/746
Acta Clin Belg
.
2022 Feb;77(1):1-3.
doi: 10.1080/17843286.2020.1787659.
Epub 2020 Jul 2.
Authors
Pieter Vermeersch
1
,
Frédéric Cotton
2
,
Dieter De Smet
3
,
Geert Martens
3
,
Matthijs Oyaert
4
,
Etienne Cavalier
5
;
Royal Belgian Society of Laboratory Medicine
Affiliations
1
Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.
2
Department of Clinical Chemistry, LHUB-ULB, Brussels, Belgium.
3
AZ Delta Medical Laboratories, AZ Delta General Hospital, Roeselare, Belgium.
4
Department of Laboratory Medicine, Clinical Chemistry, Ghent University Hospital, Ghent, Belgium.
5
Department of Clinical Chemistry, University of Liège, CHU de Liège, Liège, Belgium, etienne.cavalier@chu.ulg.ac.be.
PMID:
32615912
DOI:
10.1080/17843286.2020.1787659
No abstract available
Publication types
Letter
MeSH terms
Belgium / epidemiology
COVID-19*
Humans
Pandemics
SARS-CoV-2